Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells - PubMed (original) (raw)
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells
S Singh et al. J Exp Med. 1992.
Abstract
Inoculated immunogenic cancer cells after initial growth are potentially rejected by specific host immunity; however, the outcome of the interaction between host and inoculated cancer cells is a function of multiple factors including the route of inoculation, the number of cells, the density of antigens on the injected cancer cells, and the state of the immune system of the host. In the present study, we have examined a different kind of variable: the stroma that inoculated tumor cells initially reside in. The impetus to examine this factor arises from observations that cancer cells from several lines inoculated as fragments of solid tumors often grow progressively, whereas the same number or more than 10-fold larger numbers of identical type cells injected as a suspension are rejected, even though fragments or suspended cells are both tumorigenic at the same doses in nude mice. In the present studies, we found that: (a) indeed, cancer cells inoculated as fragments were more tumorigenic than cancer cells in suspension; (b) the tumorigenicity of suspended cancer cells was increased by injection of the cells into polyurethane sponge implants; (c) cancer cells were more tumorigenic embedded in syngeneic stroma than in transgenic antigenic stroma expressing the K216 major histocompatibility complex class I antigen; and (d) antigenic, bone marrow-derived, stromal components (presumably passenger leukocytes) were sufficient to cause rejection of immunogenic but antigenically unrelated cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
Perdrizet GA, Ross SR, Stauss HJ, Singh S, Koeppen H, Schreiber H. Perdrizet GA, et al. J Exp Med. 1990 Apr 1;171(4):1205-20. doi: 10.1084/jem.171.4.1205. J Exp Med. 1990. PMID: 2324687 Free PMC article. - In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
Elliott BE, Carlow DA, Ivimey L, Arnold M, Hampton N, Bosman P. Elliott BE, et al. Cancer Res. 1987 Sep 15;47(18):4915-23. Cancer Res. 1987. PMID: 2441856
Cited by
- Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
Zhang B, Bowerman NA, Salama JK, Schmidt H, Spiotto MT, Schietinger A, Yu P, Fu YX, Weichselbaum RR, Rowley DA, Kranz DM, Schreiber H. Zhang B, et al. J Exp Med. 2007 Jan 22;204(1):49-55. doi: 10.1084/jem.20062056. Epub 2007 Jan 8. J Exp Med. 2007. PMID: 17210731 Free PMC article. - Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.
Binder DC, Arina A, Wen F, Tu T, Zhao M, Hoffman RM, Wainwright DA, Schreiber H. Binder DC, et al. Oncoimmunology. 2016 Feb 18;5(6):e1130207. doi: 10.1080/2162402X.2015.1130207. eCollection 2016 Jun. Oncoimmunology. 2016. PMID: 27471609 Free PMC article. - Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.
Engels B, Engelhard VH, Sidney J, Sette A, Binder DC, Liu RB, Kranz DM, Meredith SC, Rowley DA, Schreiber H. Engels B, et al. Cancer Cell. 2013 Apr 15;23(4):516-26. doi: 10.1016/j.ccr.2013.03.018. Cancer Cell. 2013. PMID: 23597565 Free PMC article. - Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.
Lin KY, Lu D, Hung CF, Peng S, Huang L, Jie C, Murillo F, Rowley J, Tsai YC, He L, Kim DJ, Jaffee E, Pardoll D, Wu TC. Lin KY, et al. Cancer Res. 2007 Feb 15;67(4):1832-41. doi: 10.1158/0008-5472.CAN-06-3014. Cancer Res. 2007. PMID: 17308126 Free PMC article. - Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.
Loeffler M, Krüger JA, Niethammer AG, Reisfeld RA. Loeffler M, et al. J Clin Invest. 2006 Jul;116(7):1955-62. doi: 10.1172/JCI26532. Epub 2006 Jun 22. J Clin Invest. 2006. PMID: 16794736 Free PMC article.
References
- Transplantation. 1979 Sep;28(3):212-7 - PubMed
- Proc Natl Acad Sci U S A. 1977 Apr;74(4):1688-92 - PubMed
- Cancer Res. 1990 Jul 1;50(13):3851-8 - PubMed
- Cancer Res. 1990 Nov 15;50(22):7153-8 - PubMed
- J Exp Med. 1990 Apr 1;171(4):1205-20 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources